Master degree or equivalent in Science, Engineering or Technology. The candidates must have qualified at least one of the national level competitive exams such as NET/GATE/GPAT etc.
Masters Degree in Biological or Chemical Sciences or Bachelors degree in Engineering or Technology or Medicine with Four years of experience. Students with PhD are encouraged to apply.
Zenotech Labs invites QA and QC professionals to manage IPQA activities for injectables, oversee packaging operations, and ensure BMR/BPR review with cGMP/GDP compliance.
Preparation of registration strategy for Brazil submission. Prepare response to deficiency letter received from Anvisa, Brazil. Sun Pharma, Executive Regulatory and Business Continuity
Manager Scientific Writing involves updating / creating and reviewing scientifically / medically accurate content for commercial and medico-marketing assets. Novartis. Advanced degree in life sciences, pharmacy, medicine or related field.
The University of Science and Technology of China (USTC) research internship program provides the opportunity for graduate students or 3rd/4th year undergraduate students to participate in research projects to gain valuable experience on a variety of cutting-edge research at USTC.
M.Pharm / B.Pharm / M.Sc for Injectable Manufacturing at Amneal Pharma. Experience in bulk manufacturing/aseptic filling, control/aseptic area operation, vessel operation including CIP/SIP process handling, machine operation.
To perform the calibration of QC instruments as per calibration schedule. Overall upkeep of respective working bench as well as of the section as per GLP.
The candidate must be capable of analyzing raw materials, finished products, and stability samples. Knowledge of AMV and QAMS will be given preference.
Analytical method validation raw data and report review for different techniques like LC-MS/GC-MS/ICP -MS/ICP OES-MS for all regulated markets, Characterization & GMP Batch analysis.
Responsible and accountable for the oversight of quality operations and GMP compliance across the TPMs under responsibility of EPD Biosimilars Operations in India.
Axsome Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s supplemental New Drug Application (sNDA) for AXS-05 seeking approval for the treatment of agitation associated with Alzheimer’s disease, and has granted Priority Review designation to the filing. The regulatory body has set a Prescription Drug User Fee Act (PDUFA) target action date of April 30, 2026, underlining the importance of this potential new therapy in an area of high unmet need.
Caplin Point Laboratories Limited has announced a major strategic move to expand its presence in the regulated U.S. pharmaceutical market by acquiring ten approved Abbreviated New Drug Applications (ANDAs) for injectable and ophthalmic products from a leading multinational generic pharmaceuticals manufacturer.